Company Filing History:
Years Active: 2012-2014
Title: Frederic Petit: Innovator in Therapeutics from Orleans, France
Introduction
Frederic Petit is a notable inventor based in Orleans, France, recognized for his contributions to the field of pharmaceuticals. With a focus on innovative compounds targeting health disorders, Petit has successfully secured two patents that highlight his dedication to scientific advancement and therapeutic development.
Latest Patents
Among Frederic Petit's most significant inventions are the patents for 5,6-bisaryl-2-pyridine-carboxamide derivatives, including their preparation and therapeutic application as urotensin II receptor antagonists. These patents encompass compounds designed to interact with urotensin II receptors, which play a crucial role in regulating various physiological processes. The first patent details the general formula of these compounds and their pharmaceutical compositions, emphasizing their potential application in treating cardiac, coronary, and central nervous system disorders. The second patent reiterates the primary focus on the same derivatives, their preparation methods, and their therapeutic roles, reinforcing their promising application in modern medicine.
Career Highlights
Frederic Petit has had a distinguished career, working with prominent companies such as Sanofi-Aventis and Sanofi. His experience in these organizations has significantly contributed to his research and invention process, allowing him to develop groundbreaking therapeutics that address critical healthcare challenges.
Collaborations
Throughout his career, Frederic Petit has collaborated with esteemed professionals, including Jean-Michel Altenburger and Valerie Fossey. These partnerships have enriched his work and enhanced the innovation process, resulting in promising therapeutic options anchored in thorough scientific research.
Conclusion
Frederic Petit stands out as an inventor making meaningful strides in the pharmaceutical industry. His work on 5,6-bisaryl-2-pyridine-carboxamide derivatives exemplifies his commitment to advancing therapeutic solutions for complex health issues. As an inventor based in Orleans, France, he continues to shape the landscape of pharmaceutical innovation through his expertise and collaborations.